Literature DB >> 6524581

Studies on the urinary excretion of xanthurenic acid in diabetics.

M Hattori, Y Kotake, Y Kotake.   

Abstract

Xanthurenic acid (XA), kynurenic acid (KA) and creatinine in fasting urine were determined by reversed phase high pressure liquid chromatography in order to investigate the distortion of tryptophan metabolites in diabetes mellitus. The results of ten patients with non-insulin dependent diabetes mellitus and ten normal healthy subjects were compared. No tryptophan load test was performed in this study, because tryptophan loading produces further latent shortage of active vitamin B6 which results in exacerbation of the disease. The ratios of XA to KA and to creatinine were 0.35 +/- 0.099 (mean +/- S.D.) and 0.99 +/- 0.321 in the diabetic patients. The corresponding figures in the normal subjects were 0.17 +/- 0.064 and 0.55 +/- 0.22. Both ratios were significantly higher in the diabetic patients than in normal subjects (p less than 0.001 and p less than 0.01, respectively). This means that XA was excessively excreted in diabetic patients resulting in distortion of tryptophan metabolism. Our findings indicated that the ratios are useful to monitor excess XA excretion and also for detection of diabetes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6524581

Source DB:  PubMed          Journal:  Acta Vitaminol Enzymol        ISSN: 0300-8924


  13 in total

1.  Neopterin, a Marker of Interferon-Gamma-Inducible Inflammation, Correlates with Pyridoxal-5'-Phosphate, Waist Circumference, HDL-Cholesterol, Insulin Resistance and Mortality Risk in Adult Boston Community Dwellers of Puerto Rican Origin.

Authors:  G Oxenkrug; K L Tucker; P Requintina; P Summergrad
Journal:  Am J Neuroprot Neuroregen       Date:  2011-06

2.  Kynurenines and vitamin B6: link between diabetes and depression.

Authors:  Gregory Oxenkrug; Rebecca Ratner; Paul Summergrad
Journal:  J Bioinform Diabetes       Date:  2013-09-14

3.  Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders.

Authors:  Gregory F Oxenkrug
Journal:  J Neural Transm (Vienna)       Date:  2010-09-02       Impact factor: 3.575

Review 4.  Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways.

Authors:  Gregory Oxenkrug
Journal:  Mol Neurobiol       Date:  2013-06-28       Impact factor: 5.590

Review 5.  Serotonin-kynurenine hypothesis of depression: historical overview and recent developments.

Authors:  Gregory Oxenkrug
Journal:  Curr Drug Targets       Date:  2013-05-01       Impact factor: 3.465

Review 6.  Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.

Authors:  Ping Song; Tharmarajan Ramprasath; Huan Wang; Ming-Hui Zou
Journal:  Cell Mol Life Sci       Date:  2017-03-17       Impact factor: 9.261

7.  Loss of arylformamidase with reduced thymidine kinase expression leads to impaired glucose tolerance.

Authors:  Alison J Hugill; Michelle E Stewart; Marianne A Yon; Fay Probert; I Jane Cox; Tertius A Hough; Cheryl L Scudamore; Liz Bentley; Gary Wall; Sara E Wells; Roger D Cox
Journal:  Biol Open       Date:  2015-10-02       Impact factor: 2.422

8.  Post-Bariatric Surgery Changes in Quinolinic and Xanthurenic Acid Concentrations Are Associated with Glucose Homeostasis.

Authors:  Marie Favennec; Benjamin Hennart; Marie Verbanck; Marie Pigeyre; Robert Caiazzo; Violeta Raverdy; Hélène Verkindt; Audrey Leloire; Gilles J Guillemin; Loïc Yengo; Delphine Allorge; Philippe Froguel; François Pattou; Odile Poulain-Godefroy
Journal:  PLoS One       Date:  2016-06-21       Impact factor: 3.240

Review 9.  Vitamin B6 and Diabetes: Relationship and Molecular Mechanisms.

Authors:  Elisa Mascolo; Fiammetta Vernì
Journal:  Int J Mol Sci       Date:  2020-05-23       Impact factor: 5.923

10.  Tryptophan-kynurenine metabolism and insulin resistance in hepatitis C patients.

Authors:  G F Oxenkrug; W A Turski; W Zgrajka; J V Weinstock; P Summergrad
Journal:  Hepat Res Treat       Date:  2013-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.